Paola A. Gehrig, MD
Professor
University of North Carolina at Chapel Hill
Division of Gynecologic Oncology
101 Manning Drive
Campus Box 7572
Chapel Hill,
NC
USA
27514
Biographical Sketch: Grant funding given for this work. 2012
Papers:
7
The association of Medicaid coverage status at the time of cancer diagnosis in women with gynecologic malignancies: a population-based study
99
Preoperative thrombocytosis and leukocytosis among ovarian cancer patients is associated with postoperative death
113
The benefits of timely palliative care referral
117
Postoperative morbidity and mortality following modern pelvic exenteration
147
The HMG-CoA reductase inhibitor, simvastatin, has anti-tumorigenic effects in ovarian cancer cell lines and a genetically engineered serous ovarian cancer mouse model.
243
Surgical outcomes in patients undergoing radical vulvectomy
263
Trainee participation in surgery for ovarian cancer: impact on patient outcomes
296
Endometrial cancer survivors may serve as ambassadors for positive health behavioral change
297
The teachable moment: physician counseling and behavioral changes following a diagnosis of endometrial cancer
305
Prevalence of sexual dysfunction in women diagnosed with gynecologic malignancy
307
Association of demographic and socio-economic factors in palliative care and the choice for hospice
312
Prospective correlation of multinational association for supportive care in cancer risk index score with outcomes in neutropenic fever
368
Intra-operative handoffs and postoperative complications among gynecologic oncology patients
370
Gemcitabine and docetaxel compared to radiation or other chemotherapy regimens as adjuvant treatment for stage I-IV uterine leiomyosarcoma
419
Laparoscopy compared to laparotomy in the management of granulosa cell tumors of the ovary